ArticleNature communications2024
Author Correction: Community assessment of methods to deconvolve cellular composition from bulk gene expression.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative effects of platelets and plasma-derived mitochondria in early-phase Achilles tendon inflammation.Regenerative biomaterials · 2026Article
Corrections and comments
- Erratum for
Authors and funding
41 authors.
Brian S WhiteSage Bionetworks, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-2954-4410
Aurélien de ReynièsCentre de Recherche des Cordeliers, INSERM U1138, Université Paris Cité, Paris, France.
Aaron M NewmanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1857-8172
Joshua J WaterfallINSERM U830 and Translational Research Department, Institut Curie, PSL Research University, Paris, France.ORCID http://orcid.org/0000-0002-3762-5050
Andrew LambSage Bionetworks, Seattle, WA, USA.
Florent PetitprezProgramme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France.ORCID http://orcid.org/0000-0002-5117-6466
Yating LinXiamen University, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0001-5061-5132
Rongshan YuXiamen University, Xiamen, Fujian, China.ORCID http://orcid.org/0000-0003-2179-173X
Martin E Guerrero-GimenezInstitute of Biochemistry and Biotechnology, School of Medicine, National University of Cuyo, Mendoza, Argentina.
Sergii DomanskyiMichigan State University, East Lansing, MI, USA.
Gianni MonacoBIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, AV, Italy.ORCID http://orcid.org/0000-0002-7863-4068
Verena ChungSage Bionetworks, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-5622-7998
Jineta BanerjeeSage Bionetworks, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-1775-3645
Daniel DerrickDepartment of Biomedical Engineering, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-3305-3507
Alberto ValdeolivasHeidelberg University, Faculty of Medicine, Heidelberg, Germany.
Haojun LiXiamen University, Xiamen, Fujian, China.
Xu XiaoXiamen University, Xiamen, Fujian, China.ORCID http://orcid.org/0000-0003-3743-3582
Shun WangAginome Scientific, Xiamen, Fujian, China.ORCID https://orcid.org/0000-0003-1592-9587
Frank ZhengAmoyDx, Xiamen, Fujian, China.
Wenxian YangAginome Scientific, Xiamen, Fujian, China.ORCID http://orcid.org/0000-0002-5349-9680
Carlos A CataniaLaboratory of Intelligent Systems (LABSIN), Engineering School, National University of Cuyo, Mendoza, Argentina.
Benjamin J LangDepartment of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2205-8591
Thomas J BertusMichigan State University, East Lansing, MI, USA.
Carlo PiermarocchiMichigan State University, East Lansing, MI, USA.
Francesca P CarusoBIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, AV, Italy.ORCID http://orcid.org/0000-0002-2206-1459
Michele CeccarelliBIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, AV, Italy.ORCID http://orcid.org/0000-0002-4702-6617
Thomas YuSage Bionetworks, Seattle, WA, USA.
Xindi GuoSage Bionetworks, Seattle, WA, USA.
Julie BletzSage Bionetworks, Seattle, WA, USA.
John CollerStanford Functional Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA.
Holden MaeckerInstitute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-0795-9946
Caroline DuaultInstitute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-2742-1668
Vida ShokoohiStanford Functional Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA.
Shailja PatelTranslational Applications Service Center, Stanford University School of Medicine, Stanford, CA, USA.
Joanna E LilientalTranslational Applications Service Center, Stanford University School of Medicine, Stanford, CA, USA.
Stockard SimonSage Bionetworks, Seattle, WA, USA.
Tumor Deconvolution DREAM Challenge consortium
Julio Saez-RodriguezHeidelberg University, Faculty of Medicine, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8552-8976
Laura M HeiserDepartment of Biomedical Engineering, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-3330-0950
Justin GuinneySage Bionetworks, Seattle, WA, USA.
Andrew J GentlesDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA. andrewg@stanford.edu.ORCID http://orcid.org/0000-0002-0941-9858
Funding
Data-driven models of hematological cell fate decision and differentiationR01GM122085 · NIGMS · MICHIGAN STATE UNIVERSITY · PI PIERMAROCCHI, CARLO · 2016 to 2020
$1.8MNetwork models of differentiation landscapes for angiogenesis and hematopoiesisR35GM149261 · NIGMS · MICHIGAN STATE UNIVERSITY · PI Carlo Piermarocchi · 2023 to 2026
$1.5MNIGMS NIH HHS R01 GM122085NIGMS NIH HHS R35 GM149261
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.